Effects of Convective Therapies in Dialysis Patients

NCT ID: NCT01583309

Last Updated: 2012-04-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

146 participants

Study Classification

INTERVENTIONAL

Study Start Date

2003-11-30

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Convective therapies have been proposed for improving chronic dialysis patient outcomes, including intradialytic symptomatic hypotension.

To evaluate the frequency of sessions with intradialytic symptomatic hypotension in different types and doses of convective therapies compared with low-flux hemodialysis (HD), the investigators performed a multicentre, open-label, randomized controlled trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Uremia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

low-flux hemodialysis

Group Type NO_INTERVENTION

No interventions assigned to this group

online pre-dilution hemofiltration

Group Type EXPERIMENTAL

online pre-dilution hemofiltration

Intervention Type PROCEDURE

Online pre-dilution hemofiltration was performed with a synthetic high-flux membrane and an infusate/blood flow ratio of one

online pre-dilution hemodiafiltration

Group Type EXPERIMENTAL

online pre-dilution hemodiafiltration

Intervention Type PROCEDURE

Online pre-dilution hemodiafiltration was performed with a synthetic high-flux membrane with an infusate/blood flow ratio of 0.6 and a dialysate plus infusate rate of 700 ml/min.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

online pre-dilution hemofiltration

Online pre-dilution hemofiltration was performed with a synthetic high-flux membrane and an infusate/blood flow ratio of one

Intervention Type PROCEDURE

online pre-dilution hemodiafiltration

Online pre-dilution hemodiafiltration was performed with a synthetic high-flux membrane with an infusate/blood flow ratio of 0.6 and a dialysate plus infusate rate of 700 ml/min.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

online pre-dilution hemofiltration Technique online pre-dilution hemodiafiltration Technique

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Dialysis patients aged 18-80 years
* thrice-weekly HD or HDF for at least 6 months
* body weight less or equal to 90 Kg
* stable clinical condition
* written consent

Exclusion Criteria

* infections
* malignancies
* active systemic diseases
* active hepatitis or cirrhosis
* unstable diabetes
* diuresis higher than 200 ml/24h
* dysfunction of vascular access
* blood flow rate less than 300 ml/min
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

A. Manzoni Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof. Francesco Locatelli

Professor Francesco Locatelli

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francesco Locatelli, Professor

Role: STUDY_CHAIR

A. Manzoni Hospital, Lecco - Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ospedale S.Marta S.Venera

Acireale (CT), , Italy

Site Status

Ospedale F. Miulli

Acquaviva delle Fonti, , Italy

Site Status

Ospedale Civile

Alghero, , Italy

Site Status

Ospedale regionale di Aosta

Aosta, , Italy

Site Status

Ospedale degli Infermi

Biella, , Italy

Site Status

Ospedale SS. Trinità ASL 8

Cagliari, , Italy

Site Status

S. Michele Hospital

Cagliari, , Italy

Site Status

Ospedale Civile "P. Merlo"

La Maddalena, , Italy

Site Status

Alessandro Manzoni Hospital

Lecco, , Italy

Site Status

Ospedale "C. POMA"

Mantova, , Italy

Site Status

T. EVOLI

Melito di Porto Salvo, , Italy

Site Status

Ospedale dell'Angelo

Mestre, , Italy

Site Status

Policlinico Multimedica IRCCS

Milan, , Italy

Site Status

Federico II

Napoli, , Italy

Site Status

Ospedale San Francesco

Nuoro, , Italy

Site Status

San Giovanni di Dio

Olbia, , Italy

Site Status

Ospedale Antonio Segni

Ozieri, , Italy

Site Status

Ospedale Maggiore

Parma, , Italy

Site Status

Fondazione Maugeri

Pavia, , Italy

Site Status

Ospedale " E. AGNELLI "

Pinerolo, , Italy

Site Status

Dipartimento territoriale ASL 8

Quartu Sant'Elena, , Italy

Site Status

Ospedale S.Maria delle Croci

Ravenna, , Italy

Site Status

Azienda Ospedaliera "Bianchi Melacrino Morelli,"

Reggio Calabria, , Italy

Site Status

Ospedale Bolognini

Seriate, , Italy

Site Status

Ospedale Agostino Landolfi

Solofra, , Italy

Site Status

Ospedale San Camillo

Sorgono, , Italy

Site Status

ASL 2 Olbia - P.O. "P. Dettori",

Tempio Pausania, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Bolasco P, Altieri P, Andrulli S, Basile C, Di Filippo S, Feriani M, Pedrini L, Santoro A, Zoccali C, Sau G, Locatelli F. Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrol Dial Transplant. 2003 Aug;18 Suppl 7:vii50-4; discussion vii59-62. doi: 10.1093/ndt/gfg1080.

Reference Type BACKGROUND
PMID: 12953031 (View on PubMed)

Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, Basile C, David S, Feriani M, Montagna G, Di Iorio BR, Memoli B, Cravero R, Battaglia G, Zoccali C. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010 Oct;21(10):1798-807. doi: 10.1681/ASN.2010030280. Epub 2010 Sep 2.

Reference Type RESULT
PMID: 20813866 (View on PubMed)

Locatelli F, Altieri P, Andrulli S, Sau G, Bolasco P, Pedrini LA, Basile C, David S, Gazzanelli L, Tampieri G, Isola E, Marzolla O, Memoli B, Ganadu M, Reina E, Bertoli S, Ferrara R, Casu D, Logias F, Tarchini R, Mattana G, Passaghe M, Fundoni G, Villa G, Di Iorio BR, Pontoriero G, Zoccali C. Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial. Nephrol Dial Transplant. 2014 Jun;29(6):1239-46. doi: 10.1093/ndt/gfu031. Epub 2014 Feb 20.

Reference Type DERIVED
PMID: 24557989 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CONVESTUDY

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.